Abstract
Entecavir can significantly inhibit the replication of HBV-DNA, reduce the HBV-DNA level in blood serum. But suffering from low oral bioavailability, entecavir has low intestinal membrane permeability and poor metabolic stability. In this study, 12 different derivatives of entecavir 4′-ester were regioselectively synthesized and their apical-to-basolateral permeabilities across Caco-2 cells and HBV-DNA inhibitory efficacies were evaluated. Most of the compounds showed high permeabilities across Caco-2 cells compared with entecavir, compounds 5b and 5e also exhibited comparable anti-HBV activities with that of entecavir, especially.
Similar content being viewed by others
References
Shi C. C., Tjwa E. T., Biesta P. J., Boonstra A., Xie Q., Janssen H. L., Woltman A. M., J. Vir. Hepatitis, 2012, 19(2), 26
Pothakamuri V. S., Sven P., Verena S., Jan G., Paraskevi F., Anna G., Birgit B.B., Antoaneta M., Jerzy J., Christoph B., Michael P. M., Markus C., Heiner W., Hepatology, 2012, 55(3), 695
Jensbukh M. D., Robert E., Lanford P. D., Robert H., Purcell M. D., Hepatology, 2013, 58(5), 1533
Rehermann B., Nascimbeni M., Nat. Rev. Immunol., 2005, 5(3), 215
Fisicaro P., Valdatta C., Boni C., Massari M., Mori C., Zerbini C., Orlandini A., Sacchelli L., Missale G., Ferrari C., Hepatology, 2009, 58, 974
Daniel G., Maximilian H., Robert T., Clin. Sci., 2013, 124, 77
Han Q. J., Zhang C., Zhang J., Tian Z. G., Semin. Immunopathol, 2013, 35(1), 23
Dienstag J. L., Perrillo R. P., Schiff E. R., Bartholomew M., Vicary C., Rubin M., N. Engl. J. Med., 1995, 333, 1657
Cullen J. M., Li D. H., Brown C., Eisenberg E. J., Cundy K. C., Wolfe J., Toole J., Gibbs C., Antimicrob. Agents Chemother., 2001, 45(10), 2740
Stevens R. C., Blum M. R., Rousseau F. S., Kearney B. P., Anderson P. L., Kakuda T. N., Lichtenstein K. A., Clin. Infect. Dis., 2004, 39, 877
Marcellin P., Mommeja M. H., Sacks S. L., Lau G. K., Sereni D., Bronowicki J. P., Conway B., Trepo C., Blum M. R., Yoo B. C., Mondou E., Sorbel J., Snow A., Rousseau F., Lee H. S., Hepatology, 2004, 40, 140
Chu C. K., Ma L., Olgen S., Pierra C., Du J., Gumina G., Gullen E., Cheng Y. C., Schinazi R. F., J. Med. Chem., 2000, 43(21), 3906
Honkoop P., Deman R. A., Opin. Investig. Drugs, 2003, 12(4), 683
Tenney D. J., Levine S. M., Rose R. E., Walsh A. W., Weinheimer S. P., Discotto L., Plym M., Pokornowski K., Yu C. F., Angus P., Ayres A., Bartholomeusz A., Sievert W., Thompson G., Warner N., Locarnini S., Colonno R. J., Antimicrob. Agents Chemother., 2004, 48(9), 3498
Innaimo S. F., Seifer M., Bisacchi G. S., Standring D. N., Zahler R., Colonno R. J., Antimicrob. Agents. Chemoter., 1997, 41, 1444
Buti M., Esteban R., J. Hepatol., 2003, 39(2), 239
Benjahad A., CouRte K., Guillemont J., Mabire D., Coupa S., Poncelet A., Csoka I., Andries K., Pauwels R., de Bethune M. P., Monneret C., Bisagni E., Nguyen C. H., Grierson D. S., J. Med. Chem., 2004, 47(22), 5501
Lv Z., Sheng C., Wang T., J. Med. Chem., 2010, 53(18), 6600
Sun Y. B., Sun J., Shi S. L., Jing Y. K., Yin S. L., Chen Y., Li G., Xu Y. J., He Z. G., Mol. Pharmaceutics, 2009, 6(1), 315
Yan Z. T., Sun J., Chang Y. N., Liu Y. H., Fu Q., Xu Y. J., Sun Y. B., Pu X. H., Zhang Y. X., Jing Y. K., Yin S. L., Zhu M., Wang Y. J., He Z. G., Mol. Pharmaceutics, 2011, 8(2), 319
Balimane P. V., Tamai I., Guo A. L., Nakanishi T., Kitada H., Leibach F. H., Tsuji A., Sinko P. J., Biochem. Biophys. Res. Commun., 1998, 250, 246
Bueno A. B., Collado I., de Dios A., Domingguez C., Martin J. A., Martin L. M., Matinez-Grau M. A., Montero C., Pedregal C., Catlow J., Coffey D. S., Cley M.P., Dantzig A. H., Lindstrom T., Monn J. A., Jiang H. Y., Schoepp D. D., Stratford R. E., Tabas L. B., Tizaano J. P., Wright R. A., Herin M. F., J. Med. Chem., 2005, 48(16), 5305
Zhang Y. X., Sun J., Gao Y. K., Jin L., Xu Y. J., Lian H., Sun Y. B., Sun Y. H., Liu J. Y., Fan R., Zhang T. H., He Z. G., Mol. Pharmaceutics, 2013, 10(8), 3195
Perkins E. J., Abraham T., Drug Metab. Dispos., 2007, 35(10), 1903
Gregory Y., Todd W., Steven I., Gregory S. B., Peter E., Kent R., Robert Z., Richard J. C., Antimicrob. Agents Chemother., 1999, 43(1), 190
Liu Y., Lu B. W., Lu J. R., Xin C. W., Li J. F., Mu J. B., Bao X. R., Chem. Res. Chinese Universities, 2013, 29(3), 449
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National Natural Science Foundation of China(No.51209024) and the Science and Technology Plan of Sichuan Province, China(No.2010JY0122).
This article is retracted because the corresponding author XU Youjun was put as the corresponding author without knowing anything before its publication. All were arranged by the first author, Mr. FENG Deri, in abnormal ways. Hence all other authors and XU states here that this paper has no relation with other authors and with Xu’s working university. XU also states that he has never used “xuyoujun65@163.com”as corresponding author contact email. Therefore XU declares that the paper should be withdrawn from the journal as soon as possible in case any negative effects on other authors and on this journal.
About this article
Cite this article
Feng, D., Liu, J., Liang, S. et al. RETRACTED ARTICLE: Synthesis and biological evaluation of entecavir 4′-ester derivatives. Chem. Res. Chin. Univ. 30, 749–754 (2014). https://doi.org/10.1007/s40242-014-4183-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40242-014-4183-y